Abstract
The physician of the 1980s has a vast therapeutic armamentarium at his disposal with which to treat his patient. While in some countries, e. g. Germany, the number of preparations may exceed 10 000, in the UK some 3000 preparations are listed in the monthly index of medical supplies (MIMS). There are perhaps 1000 pharmacologically active drugs available for prescription and the potential pairs of drugs that might interact is therefore about 500 000. Patients admitted to hospital on average receive 4 or 5 drugs during the course of a hospital admission, and one in every five patients receives at least ten drugs (Crooks and Moir, 1974). There is little doubt that in the last ten years the exposure of patients to drugs has increased and this applies to both hospital and general practice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abe, K., Itoh, T., Imai, Y., Sato, M., Haruyama T., Sakurai Y., Goto, T., Otsuka Y. and Yoshinaga, K. (1980) Implication of endogenous prostaglandin system in the antihypertensive effect of Captopril SQ 14225 in low renin hypertension. Jap. Circ. J., 44, 422–5.
Adams, J. D. and Hunter, G. A. (1976) Drug interactions in psoriasis. Aust. J. Dermatol., 17, 39–40.
Aggeler, P. M., O’Reilly, R. A., Leong, L. and Kowitz, P. E. (1967) Potentiation of anticoagulant effect of warfarin by phenylbutazone. N. Engl. J. Med., 276, 496–501.
Allan, S. G., Knox, J. and Kerr, F. (1981) Interaction between diuretics and indomethacin. Br. Med. J., 283, 1611.
Alvan, G. and Ekstrand, R. (1981) Clinical effects of indomethacin and additive clinical effect of indomethacin during salicylate maintenance therapy. Scand. J. Rheumatol., 39, (Suppl.), 29–32.
Anderson, C. J., Kaufman, P. L. and Sturm, R. J. (1978) Toxicity of combined therapy with carbonic anhydrase inhibitors and aspirin. Am. J. Ophthalmol., 86, 516–19.
Anderson, W. P., Bartley, P. J., Casley, D. J. and Selig, S. E. (1983) Comparison of aspirin and indomethacin pre-treatment on the responses to reduced renal artery pressure in conscious dogs. J. Physiol., 336, 101–12.
Andreasen, P. B., Froland, A., Skovsted, L., Anderson, S. A. and Hauge, M. (1973) Diphenylhydantoin half life in man and its inhibition by phenylbutazone: the role of genetic factors. Acta Med. Scand., 193, 561–4.
Andreasen, P. B., Simonsen, K., Brocks, K., Dimo, B. and Bouchelouche, P. (1981) Hypoglycaemia induced by azapropazone — tolbutamide interaction. Br. J. Clin. Pharmacol., 12, 581–3.
Angelkort, B. (1978) Zum Einfluss von naproxen auf die thrombozytare Blutstillung und die Antikoagulantien — Behandlung mit phenprocoumon. Fortschr. Med., 15, 1249–52.
Arenberg, I. K. and Goodfriend, T. L. (1980) Indomethacin blocks the acute audiologic effects of furoside in Meniere’s disease. Arch. Otolarynyol., 106, 383–6.
Attallah, A. A. (1979) Interaction of prostaglandins with diuretics. Prostaglandins, 18, 369–75.
Ayres, J. W., Wiedler, D. J., Mackichen, J., Sakmar, E., Hallmark, M. R., Lemanowicz, E. F. and Wagner, J. G. (1977) Pharmacokinetics of tolmetin with and without concomitant administration of antacid in man. Eur. J. Clin. Pharmacol., 12, 421–8.
Baber, N., Halliday, L., Sibeon, R., Littler, T. and Orme, M. (1978) The interaction between indomethacin and probenecid. A clinical and pharmacokinetic study. Clin. Pharmacol. Ther., 24, 298–307.
Baele, G., Rasquin, K. and Barbier, F. (1983) Effects of oxametacin on coumarin anticoagulation and on platelet function in humans. Arzneim. Forsch., 33, 149–52.
Baragar, F. D. and Smith, T. C. (1978) Drug interaction studies with sodium meclofe-namate (Meclomen). Curr. Ther. Res., 23, S51–S59.
Bartoli, E., Arras, S., Faedda, R., Soggia, G., Satta, A. and Olmeo, N. A. (1980) Blunting of furosemide diuresis by aspirin in man. J. Clin. Pharmacol., 20, 452–8.
Basu, T. K. (1982) Vitamin C — aspirin interactions. Int. J. Vit. Nutr. Res., 23, 83–90.
Bird, H. A., le Gallez, P. and Wright, V. (1983) Drowsiness due to haloperidol/ indomethacin in combination. Lancet, i, 830–1.
Birkett, D. J., Miners, J. O. and Attwood, J. (1983) Evidence for a dual action of sulphinpyrazone on drug metabolism in man: theophylline — sulphinpyrazone interaction. Br. J. Clin. Pharmacol., 15, 567–9.
Boejinga, J. K. and Van der Vijgh, W. J. (1977) Double blind study of the effect of glafenine (Glifanan) on oral anticoagulant therapy with phenprocoumon (Marcumar). Eur. J. Clin. Pharmacol., 12, 291–6.
Boekhout-Mussert, M. J. and Loeliger, E. A. (1974) Influence of ibuprof en on oral anticoagulation with phenprocoumon. J. Int. Med. Res., 2, 297–83.
Boost, G. (1975) Klinisch-pharmakologische und Pharmakokinetische Studien mit Naproxen. Arzneim. Forsch., 25, 281–7.
Brater, D. C. (1979) Analysis of the effect of indomethacin on the response to furosemide in man: effect of dose of furosemide. J. Pharmacol. Exp. Ther., 210, 386–390.
Brater, D, C, Fox, W. R. and Chennavasin, P. (1981) Interaction studies with bumeta-nide and furosemide. Effects of probenecid and of indomethacin on response to bumetanide in man. J. Clin. Pharmacol., 21, 647–53.
Brazier, J. L., Tamisier, J. N., Ambert, D. and Bannier, A. (1981) Bioavailability of ketoprofen in man with and without concomitant administration of aluminium phosphate. Eur. J. Clin. Pharmacol., 19, 305–7.
Brink, C, Grimauld, C, Guillot, C. and Orehek, J. (1980) The interaction between indomethacin and contractile agents on human isolated airway muscle. Br. J. Pharmacol., 69, 383–8.
Brogden, R. N., Heel, R. C., Speight, T. M. and Avery, G. S. (1981) Piroxicam: a review of its pharmacological properties and therapeutic efficacy. Drugs, 22, 165–87.
Brooks, P. M., Bell, M. A., Lee, P., Rooney, P. J. and Dick, W. C. (1974a) The effect of frusemide on indomethacin plasma levels. J. Clin. Pharmacol., 1, 485–9.
Brooks, P. M., Bell, M. A., Mason, D. I. and Buchanan, W. W. (1977) Interactions of anti-rheumatic drugs. Agents Actions (Suppl. 1), 85–95.
Brooks, P. M., Bell, M. A., Sturrock, R. D., Famoey, J. P. and Dick, W. C. (1974b) The clinical significance of the indomethacin-probenecid interaction. Br. J. Clin. Pharmacol., 1, 287–90.
Brooks, P. M. and Khong, T. K. (1977) Flurbiprofen-aspirin interaction: a double-blind crossover study. Curr. Med. Res. Opinion, 5, 53–7.
Brooks, P. M., Walker, J. J., Bell, M. A., Buchanan, W. W. and Rhymer, A. R. (1975) Indomethacin-aspirin interaction: a clinical appraisal. Br. Med. J., 3, 69–71.
Bunning, R. D. and Barth, W. F. (1982) Sulindac — a potentially renal sparing nonsteroidal anti-inflammatory drug. J. Am. Med. Assoc., 248, 2864–7.
Calabresi, P. and Parks, R. E. (1980) Chemotherapy of neoplastic diseases, in The Pharmacological Basis of Therapeutics (eds A. G. Gilman, L. S. Goodman and A. Gilman), MacMillans, New York, pp. 1249–313.
Calin, A. (1981) Non-steroidal anti inflammatory drugs and frusemide-induced diuresis. Br. Med. J., 283, 1399–400.
Carter, S. A. (1979) Potential effect of sulindac on response of prothrombin time to oral anticoagulants. Lancet, ii, 698–9.
Chalmers, I. M., Bell, M. A. and Buchanan, W. W. (1973) Effect of flurbiprofen on the metabolism of antipyrine in man. Ann. Rheum. Dis., 32, 58–61.
Champion, G. D., Paulus, H. E., Mongan, E., Okun, R., Pearson, C. M. and Sarkissian, E. (1972) The effect of aspirin on serum indomethacin. Clin. Pharmacol. Ther., 13, 239–44.
Chatfield, D. H., Green, J. N., Kao, J. C, Tarrant, M. E. and Woodage, T. J. (1978) Plasma protein binding and interaction studies with benoxaprofen. Biochem. Pharmacol., 27, 887–90.
Chennavasin, P., Seiwell, R. and Brater, D. C. (1980) Pharmacokinetic-dynamic analysis of the indomethacin-frusemide interaction in man. J. Pharmacol. Exp. Ther., 215, 77–81.
Cherner, R., Groppe, C. W. and Rupp, J. J. (1963) Prolonged tolbutamide-induced hypoglycaemia. J. Am. Med. Assoc., 185, 883–4.
Chernish, S. M., Rubin, A., Rodda, B. E. and Ridolfo, A. S. (1972) The physiological disposition of fenoprofen IV. The effects of position of subject, food ingestion, antacid ingestion on the plasma levels of orally administered fenoprofen. J. Med., 3, 249–57.
Chiccarelli, F. S., Eisner, H. J. and Van Lear, G. E. (1980) Metabolic and pharmacokinetic studies with fenbufen in man. Arzneim. Forsch., 30, 728–35.
Chignell, C. F. and Stark Weather, D. K. (1971) Optical studies of drug protein complexes V. The interaction of phenylbutazone, flufenamic acid, and dicoumarol with acetyl salicylic acid treated human serum albumin. Mol. Pharmacol., 7, 229–37.
Chlud, K. (1976) Investigations with possible interactions between diclofenac and glibenclamide. Z. Rheumaforsch., 35, 377–82.
Chlud, K. and Kaik, B. (1977) Clinical studies of the interaction between tolmetin and glibenclamide. Int. J. Clin. Pharmacol., 15, 409–10.
Christensen, L. K., Hansen, J. M. and Kristenson, M. (1963) Sulphaphenazole induced hypoglycaemic attacks in tolbutamide-treated diabetics. Lancet, ii, 1298–301.
Conney, A. H. (1967) Pharmacological implications of enzyme induction. Pharmacol. Rev., 19, 317–66.
Conrad, K. A. and Mayersohn, M. (1983) Cimetidine does not affect single dose ibuprofen kinetics in volunteers. Proc. 2nd World Conf. Clin. Pharmacol. Ther., Abstract No. 668.
Consolo, S., Morselli, P. L., Zaccala, M. and Garattini, S. (1970) Delayed absorption of phenylbutazone caused by desmethylimipramine in humans. Eur. J. Pharmacol., 10, 239–42.
Corell, T, and Jensen, K. M. (1979) Interaction of salicylates and other non-steroidal anti-inflammatory agents in rats as shown by gastro-ulcerogenic and anti-inflammatory activities, and plasma concentrations. Acta Pharmacol. Toxicol., 45, 225–31.
Cremoncini, C, Vignati, E., Cremoncini, M., Libroia, A. and Valente, M. C. (1980) Study on interaction between oral antidiabetic drugs and flurbiprofen. Br. J. Clin. Pract., Suppl. 9, 27–9.
Cressman, W. A., Wortham, F. and Plostnieks, J. (1976) Absorption and excretion of tolmetin in man. Clin. Pharmacol. Ther., 19, 224–33.
Crooks, J. and Moir, D. C. (1974) The detection of drug interaction in a hospital environment, in Clinical Effects of Interaction between Drugs (eds L. E. Cluff and J. C. Pétrie) Excerpta Medica, Amsterdam, pp. 255–62.
Das, U. N. (1982) Modification of anti-hypertensive action of verapamil by inhibition of endogenous prostaglandin synthesis. Prostaglandins Leukotrienes Med., 9, 167–9.
Data, J. L., Rane, A., Gerkens, J., Wilkinson, G. R., Nies, A. S. and Branch, R. A. (1978) The influence of indomethacin on the pharmacokinetics, diuretic response and hemodynamics of frusemide in the dog. J. Pharmacol. Exp. Ther., 206, 431–8.
Day, R. O., Graham, G. G., Champion, G. D. and Lee, E. (1982) Clinically significant drug interactions with anti-rheumatic drugs, in Anti-Rheumatic Drugs (ed. E. Huskisson), Praeger, Basle, pp. 37–54.
De Forrest, J. M., Waldron, T. L. and Antonaccio, M. J. (1982) Renal response to Captopril in conscious dogs pretreated with indomethacin. Am. J. Physiol., 243, F543-F548.
Desiraju, R. K., Nayak, R. K., Pritchard, J. F. (1983) Zomepirac-aspirin interactions in man. Clin. Pharmacol. Ther., 33, 250.
Dessaulies, E. and Schwartz, J. (1979) A comparative study of the action of frusemide and methylchlorthiazide on renin release by rat kidney slices and the interaction with indomethacin. Br. J. Pharmacol., 65, 193–6.
Diwan, P. V. and Kulkarni D. R. (1983) Influence of non-steroidal anti-inflammatory agents on tolbutamide hypoglycaemia. Ind. J. Med. Res., 78, 147–50.
Donaldson, D. R., Sreeharan, N., Crow, M. J. and Rajad, S. M. (1982) Assessment of the interaction of warfarin with aspirin and dipyridamole. Thrombosis Haemostasis, 47, 77.
Dresse, A., Gerard, M. A., Quinaux, N., Fischer, P. and Gerardy, J. (1978) Effect of diflunisal on the human plasma levels and on the urinary excretion of naproxen. Arch. Int. Pharmacodynam. Ther., 236, 276–84.
Dugal, R., Dupuis, C., Bertrand, M. and Gagnon, M. A. (1980) The effect of buffering on oxyphenbutazone absorption kinetics and systemic availability. Biopharm. Drug Disposition, 1, 307–21.
Dunky, A., Ogris, E., Eberl, R. and Sailer, V. (1979) Interaction study with digoxin and fenbufen. IXth Eur. Rheumatol. Congr., Wiesbaden, Abstract No. 315.
Dunn, M. J. and Hood, V. L. (1977) Prostaglandins and the kidney. Am. J. Physiol., 233, F169–F184.
Durao, V., Prata, M. M. and Goncalves, L. M. P. (1977) Modification of antihypertensive effect of ß-adrenoceptor-blocking agents by inhibition of endogenous prostaglandin synthesis. Lancet, ii, 1005–7.
Düsing, R., Nicholas, V., Glatte, B., Glänzer, K., Kipnowski, J. and Kramer, H. J. (1983) Interaction of bemetizide and indomethacin in the kidney. Br. J. Clin. Pharmacol., 16, 377–84.
Edou, D., Godin, M., Colonna, L., Petit, M. and Fillastre, J. P. (1983) Interaction médicamenteuse: clométacine-lithium. Presse Méd., 12, 1551.
Eisen, M. J. (1964) Combined effect of sodium warfarin and phenylbutazone. J. Am. Med. Assoc., 189, 64–5.
Ekstrand, R., Alvan, G., Magnusson, A., Oliw, E., Palmer, L. and Rane, A. (1981) Additive clinical effect of indomethacin suppositories during salicylate therapy in rheumatoid patients. Scand. J. Rheumatol., 10, 69–75.
Elion, G. B. (1978) Allopurinol and other inhibitors of urate synthesis, in Handbook of Experimental Pharmacology (eds W. N. Kelley and I. M. Weiner), Vol. 51, Springer-Verlag, Berlin, pp. 485–514.
Elliot, H. C. (1962) Reduced adrenocortical steroid excretion rates in man following aspirin administration. Metabolism, 11, 1015–18.
Emori, H. W., Paulus, H. E., Bluestone, R., Champion, G. D. and Pearson, C. (1976) Indomethacin serum concentrations in man. Effects of dosage, food and antacids. Ann. Rheum. Dis., 35, 333–8.
Fanelli, G. M., Böhm, D. L., Camp, A. E. and Shum, W. K. (1980) Inability of indomethacin to modify hydrochlorthiazide diuresis and natriuresis by the chimpanzee kidney. J. Pharmacol. Exp. Ther., 213, 596–9.
Farrell, K., Orr, J. M., Abbott, F. S., Ferguson, S., Sheppard, I., Godolphin, W. and Bruni, J. (1982) The effect of acetylsalicylic acid on serum free valproate concentrations and valproate clearance in children. J. Paediatr., 101, 142–4.
Fausa, O. (1970) Salicylate-induced hypoprothrombinaemia. A report of four cases. Acta Med. Scand., 188, 403–8.
Faust-Tinnefeldt Von, G. and Geissler, H. E. (1978) Azapropazone and rheumatic combination therapy considering drug interactions: azapropazone, aurothioglu-cose and azapropazone prednisolone. Arzneim. Forsch., 28, 337–41.
Faust-Tinnefeldt Von, G., Geissler, H. E. and Gilfrich, H. J. (1979) Azapropazone — Plasmaspiogel während kombinierten Anwendung mit Digitoxin. Medizin. Welt, 30, 181–2.
Faust-Tinnefeldt Von, G., Geissler, H. E. and Mutschier, E. (1977) Azapropazone Plasmaspiegel unter Begleitmedikation mit einen Antacidun oder Laxans. Arzneim. Forsch., 27, 2411–14.
Faust-Tinnefeldt Von, G. and Gilfrich, H. J. (1977) Kinetics of digitoxin during antirheumatic therapy with azapropazone. Arzneim. Forsch., 27, 2009–11.
Favre, L., Glasson, Ph., Riondel, A. and Valloton, M. B. (1983) Interaction of diuretics and non-steroidal anti-inflammatory drugs in man. Clin. Sci., 64, 407–15.
Favre, L., Glasson, P. and Vallotton, M. B. (1982) Reversible acute renal failure from combined triamterene and indomethacin: a study in healthy subjects. Ann. Intern. Med., 96, 317–20.
Fenster, P. E., Comess, K. A., Hanson, C. D. and Finley, P. R. (1982) Kinetics of the digoxin-aspirin combination. Clin. Pharmacol. Ther., 32, 428–30.
Field, J. B., Ohta, M., Boyle, C. and Remer, A. (1967) Potentiation of acetohexamide hypoglycaemia by phenylbutazone. N. Engl. J. Med., 277, 889–94.
Finch, M. B., Kelly, J. G., Johnston, G. D. and McDevitt, D. G. (1983) Evidence against a digoxin-indomethacin interaction. Br. J. Clin. Pharmacol., 16, 212–13P.
Fleitman, J. S., Bruni, J., Perrin, J. H. and Wilder, B. J. (1980) Albumin binding interactions of sodium valproate. J. Clin. Pharmacol., 20, 514–17.
Fowler, P. D. (1979) Diclofenac sodium (voltarol). Drug interactions and special studies. Rheumatol. Rehabii, Suppl. 2, 60–8.
Fraser, D. G., Ludden, T. M., Evens, R. P. and Sutherland, E. W. (1980) Displacement of phenytoin from plasma binding sites by salicylate. Clin. Pharmacol. Ther., 27, 165–9.
Frölich, J. C., Leftwich, R., Ragheb, M., Oates, J. A., Reimann, I. and Buchanan, D. (1979) Indomethacin increases plasma lithium. Br. Med. J., 1, 1115–16.
Fujita, T., Yamashita, W. and Yamashita, K. (1981) Effect of indomethacin on antihypertensive action of Captopril in hypertensive patients. Clin. Exp. Hypertension, 3, 939–52.
Fujita, T., Ando, K., Sato, Y. and Yamashita, K. (1982) Effect of indomethacin on responses to [Sarileu]-angiotensin II. Clin. Pharmacol. Ther., 32, 366–70.
Galeazzi, R. L. (1977) The effect of an antacid on the bioavailability of indomethacin. Eur. J. Clin. Pharmacol., 12, 65–8.
Garnham, J. C., Raymond, K., Shotton, E. and Turner, P. (1975) The effect of buffered aspirin on plasma indomethacin. Eur. J. Clin. Pharmacol., 8, 107–13.
Garnham, J. C., Kaspi, T., Kaye, C. M. and Oh, V. M. S. (1977) The different effects of sodium bicarbonate and aluminium hydroxide on the absorption of indomethacin in man. Postgrad. Med. J., 53, 126–9.
Garrett, R., Manthey, B., Vernon-Roberts, B. and Brooks, P. M. (1983) Assessment of non-steroidal anti-inflammatory drug combinations by the polyurethane sponge implantation model in the rat. Ann. Rheum. Dis., 42, 439–42.
Geaney, D. P., Carver, J. G., Aronson, J. K. and Warlow, C. P. (1982) Interaction of azapropazone with phenytoin. Br. Med. J., 284, 1373.
Gerkens, J. F., Shand, D. G., Flexner, C., Nies, A. S., Oates, J. A. and Data, J. L. (1977) Effect of indomethacin and aspirin on gastric blood flow and acid secretion. J. Pharmacol. Exp. Ther., 203, 646–52.
Giugliano, D, and D’Onofrio, F. (1980) Acetylsalicylic acid in human diabetes, in Guidelines to Metabolic Therapy, Vol. 9, Upjohn Company, Kalamazoo, Michigan, USA, pp. 3–4.
Graham, G. G., Champion, G. D., Day, R. O. and Paul, P. D. (1977) Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis. Clin. Pharmacol. Ther., 22, 410–20.
Green, A. E., Hort, J. F., Korn, H. E. T. and Leach H. (1977) Potentiation of warfarin by azapropazone. Br. Med. J., 1, 1532.
Greenblatt, D. J. and Abernethy, D. R. (1983) Ibuprofen does not impair antipyrine clearance. Clin. Pharmacol. Ther., 33, 267.
Grennan, D. M., Ferry, D. G., Ashworth, M. E., Kenny, R. E. and MacKinnon, M. (1979) The aspirin-ibuprofen interaction in rheumatoid arthritis. Br. J. Clin. Pharmacol., 8, 497–503.
Grennan, D. M., Karetai, M. and Palmer, D. G. (1977) Drug prescribing in rheumatoid arthritis in Otago. N. Z. Med. J., 86, 130–2.
Gross, D., Rau, R. and Hind, I. D. (1980) Effect of flurbiprofen on steady-state levels and excretion of digoxin. Br. J. Clin. Pract., Suppl. 9, 20–6.
Grygiel, J. J., Wing, L. M. H., Farkas, J. and Birkett, D. J. (1979) Effects of allopurinol on theophylline metabolism and clearance. Clin. Pharmacol. Ther., 26, 660–7.
Gulbrandsen, R. (1959) Okt tolbutamid-effect. ted hjelp au fenylbutazon. Tiddsskrift for den Nor ska Laegeforening, 79, 1127–8.
Gupta, K. C, Joshi, J. V., Hazari, K., Pohujani, S. M. and Satoskar, R. S. (1982) Effect of low estrogen combination oral contraceptive on metabolism of aspirin and phenylbutazone. Int. J. Clin. Pharmacol. Ther. Toxicol., 20, 511–3.
Hansen, J. M. and Christensen, L. K. (1977) Drug interactions with oral sulphonylurea drugs. Drugs, 13, 24–34.
Hayes, A. H. (1981) Therapeutic implications of drug interactions with acetaminophen and aspirin. Arch. Intern. Med., 141, 301–4.
Helleberg, L. (1981) Clinical pharmacokinetics of indomethacin. Clin. Pharmacokinet., 6, 245–58.
Helleberg, L., Rubin, A., Wolen, R. L., Rodda, B. E., Ridolfo, A. S. and Gruber, C. M. J. (1974) A pharmacokinetic interaction in man between phenobarbitone and fenoprofen, a new anti-inflammatory agent. Br. J. Clin. Pharmacol., 1, 371–4.
Helleberg, L., Gylding-Sabroe, J. and Sylvest, J. (1977) The effect of aspirin upon the physiological disposition of indomethacin in man. Scand. J. Rheumatol., 6, 71.
Hemming, J. D., Bird, H. A., Pickup, M. E., Saunders, A., Lowe, J. R. and Dixon, J. S. (1981) Bioavailability of aspirin in the presence of dextropropoxyphene/paracetamol combination. Pharmacotherapeutica, 2, 543–6.
Heuer, L. J. (1983) Interaktion zwischen Antihypertensiva und Antirheumatika. Deutsch Medizin. Wochenschr., 108, 268–71.
Hierton, C. (1981) Effects of indomethacin, naproxen and paracetamol on regional blood flow in rabbits. Acta Pharmacol. Toxicol., 49, 327–33.
Hirns, S. and Königstein, R. P. (1969) HB419 Ein neues orales Antidiabetikum und sein Anwendung im hohen Alter. Wiener Medizin. Wochenschr., 119, 632–3.
Hobbs, C. B., Miller, A. L., Thornley, J. H. (1965) Potentiation of anticoagulant therapy by oxyphenbutaxone. Postgrad. Med. J., 41, 563–65.
Hobbs, D. C. and Twomey, T. M. (1979) Piroxicam pharmacokinetics in man: aspirin and antacid interaction studies. J. Clin. Pharmacol., 19, 270–81.
Hobkirk, D., Rhodes, M. and Haslock, I. (1977) Night medication in rheumatoid arthritis. II Combined therapy with indomethacin and diazepam. Rheumatol. Rehabil., 16, 125–7.
Hoffbrand, B. I. and Kininmonth, D. A. (1967) Potentiation of anticoagulants. Br. Med. J., 2, 838–9.
Holmes, E, L. (1967) Pharmacology of the fenamates. IV Toleration by normal human subjects. Ann. Phys. Med., 9 (Suppl.), 36–49.
Holmes, G. I., Irvin, J. D., Schrogie, J. J., Davies, R. O., Breault, G. O., Rogers, J. D., Huber, P. B. and Zinny, M. A. (1979) Effects of Maalox on the bioavailability of diflunisal. Clin. Pharmacol. Ther., 25, 229.
Horwitz, D., Thorgeirsson, S. S. and Mitchell, J. R. (1977) The influence of allopurinol and size of dose on the metabolism of phenylbutazone in patients with gout. Eur. J. Clin. Pharmacol., 12, 133–6.
Howes, C. A., Pullar, T., Sourindhrin, I., Mistra, P. C, Capell, H., Lawson, D. H. and Tilstone, W. J. (1983) Reduced steady-state plasma concentrations of chlorpromazine and indomethacin in patients receiving Cimetidine. Eur. J. Clin. Pharmacol., 24, 99–102.
Humphrey, S. J. and Zins, G. R. (1983) The effects of indomethacin on systemic hemodynamics and blood flow in the conscious dog. Res. Commun. Chem. Pathol. Pharmacol., 39, 229–40.
Inoue, F. and Walsh, R. J. (1983) Folate supplements and phenytoin-salicylate interaction. Neurology, 33, 115–16.
Jackson, S. H. D. and Pickles, H. (1983) Indomethacin does not attenuate the effects of hydralazine in normal subjects. Eur. J. Clin. Pharmacol., 25, 303–6.
Jacono, A., Caso, P., Gualtieri, S., Raucci, D., Bianchi, A., Vigorito, C., Bergamini, N. and Iadeviaa, V. (1981) Clinical study of possible interactions between indoprofen and oral anticoagulants. Eur. J. Rheumatol. Inflammation, 4, 32–5.
Jain, A., McMahon, F. G., Slattery, J. T. and Levy, G. (1979) Effect of naproxen on steady-state serum concentration and anticoagulant activity of warfarin. Clin. Pharmacol. Ther., 25, 61–6.
Jeremy, R, and Towson, J. (1970) Interaction of aspirin and indomethacin in the treatment of rheumatoid arthritis. Med. J. Aust., 2, 127–9.
Jubiz, W. and Meikle, A. W. (1979) Alterations of glucocorticoid actions by other drugs and disease states. Drugs, 18, 113–21.
Kaldestadt, E., Hansel, T. and Brath, H. K. (1975) Interaction of indomethacin and acetylsalicylic acid as shown by the serum concentrations of indomethacin and salicylate. Eur. J. Clin. Pharmacol., 9, 199–207.
Kampmann, J., Hansen, J. M., Siersback-Nielsen, K. and Laursen, H. (1972) Effect of some drugs on penicillin half-life in blood. Clin. Pharmacol. Ther., 13, 516–19.
Kaufmann, E. (1977) Effect of alclofenac on the prothrombin level in patients under treatment with anticoagulants. Schweizische Medizin. Wochenschr., 107, 882–7.
Keber, I., Jerse, M., Keber, D. and Stegnar, M. (1979) The influence of combined treatment with propranolol and acetylsalicylic acid on platelet aggregation in coronary heart disease. Br. J. Clin. Pharmacol., 7, 287–91.
Kerry, R. J., Owen, G. and Michaelson, S. (1983) Possible toxic interaction between lithium and piroxicam. Lancet, i, 418–19.
Kirch, W., Spahn, H., Ohnhaus, E., Köhler, H., Heinz, U. and Mutschier, E. (1983) Influence of inflammatory disease on the clinical pharmacokinetics of atenolol and metoprolol. Biopharm. Drug Dis., 4, 73–81.
Klinenberg, J. R. and Miller, F. (1965) Effect of corticosteroids on salicylate concentration. J. Am. Med. Assoc., 194, 601–4.
Kondo, K., Oka, T., Ohashi, K., Touru, M. and Ebihara, A. (1983) Drug interaction between furosemide and indomethacin: effect of small dose of indomethacin on furosemide-induced natriuresis. Proc. 2nd World Congr. Clin. Pharmacol., Abstract No. 251.
Koren, G., Zarfin, Y., Perlman, M. and MacLeod, S. M. (1983) Influence of indomethacin on digoxin pharmacokinetics in pre-term infants. Proc. 2nd World Conf. Clin. Pharmacol. Ther., Abstract No. 32.
Kristensen, M. and Christensen, L. K. (1969) Drug-induced changes of the blood glucose lowering effect of oral hypoglycaemic agents. Acta diabetica latina, 6 (Suppl. 1), 116–36.
Krzywanek, H. J. and Breddin, K. (1977) Beeinflusst Diclofenac die orale Antikoagu-lantienstherapie und die Plaettchenaggregation. Medizin. Welt, 28, 1843–5.
Kwan, K. C, Breault, G. O., Davis, R. L., Lei, B. W., Czerwinski, A. W., Besselaar, G. H. and Duggan, D. E. (1978) Effects of concomitant aspirin administration on the pharmacokinetics of indomethacin in man. J. Pharmacokin. Biopharm., 6, 451–76.
Lanza, F. L., Royger, G. L. and Nelson, R. S. (1980) Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N. Engl. J. Med., 303, 136–8.
Lee, K. Y., Beilin, L. J. and Vandongen, R. (1979) Severe hypertension after ingestion of an appetite suppressant (phenylpropanolamine) with indomethacin. Lancet, i, 1110–11.
Leftwich, R., Walker, L. and Smigel, M. (1977) Indomethacin is antidiuretic in lithium-induced diabetes insipidus. Clin. Res., 25, 272A.
Leonard, R. F., Knott, P. J., Rankin, G. O., Robinson, D. S. and Melnick, D. E. (1981) Phenytoin-salicylate interaction. Clin. Pharmacol. Ther., 29, 56–60.
Leonards, R. F. and Levy, G. (1969) Reduction or prevention of aspirin-induced occult gastrointestinal blood loss in man. Clin. Pharmacol. Ther., 10, 571–4.
Levy, G., Lampman, T., Kamath, B. L. and Garettson, L. K. (1975) Decreased serum salicylate concentrations in children with rheumatic fever treated with antacid. N. Engl. J. Med., 293, 323–5.
Lewis, R. J., Trager, W. F., Chan, K. K., Breckenridge, A., Orme, M., Rowland, M. and Schary, W. (1974) Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone. J. Clin. Invest., 53, 1607–17.
Liegler, D. G., Henderson, E. S., Hahn, M. A. and Oliverio, V. T. (1969) The effect of organic acids on renal clearance of methotrexate in man. Clin. Pharmacol. Ther., 10, 849–57.
Lindquist, B., Jensen, K. M., Johansson, H. and Hansen, T. (1974) Effect of concurrent administration of aspirin and indomethacin on serum concentrations. Clin. Pharmacol. Ther., 15, 247–52.
Livio, M., Del Maschio, A., Cerletti, C. and de Gaetano, G. (1982) Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity. Prostaglandins, 23, 787–96.
Loftin, J. P. and Vesell, E. S. (1979) Interaction between sulindac and warfarin: different results in normal subjects and in an unusual patient with a potassium-losing renal tubular defect. J. Clin. Pharmacol., 19, 733–42.
Lopez-Ovejero, J. A., Weber, M. A., Drayer, J. M., Sealey, J. E. and Laragh, J. H. (1978) Effects of indomethacin alone and during diuretic or β-adrenoceptor blocking therapy on blood pressure and the renin system in essential hypertension. Clin. Sci. Mol. Med., 55, 203S-205S.
Lyle, W. H., Pearcey, D. F. and Hui, M. (1977) Inhibition of penicillamine-induced cupresis by oral iron. Proc. R. Soc. Med., 70 (Suppl. 3), 48–9.
MacCarthy, E. P., Frost, G. W. and Stokes, G. S. (1979) Indomethacin-induced hyperkalemia. Med. J. Aust., 1, 550.
McElnay, J. C. and D’Arcy, P. F. (1977) Interaction between azapropazone and warfarin. Br. Med. J., 2, 773–4.
Mahfouz, M., Abdel-Maguid, R. and El-Dakhakny, M. (1970) Potentiation of the hypoglycaemic action of tolbutamide by different drugs. Arzneim. Forsch., 20, 120–2.
Mandel, M. A. (1976) The synergistic effect of salicylates on methotrexate toxicity. Plastic Reconstruct. Surg., 57, 733–7.
Manfredi, R. and Vesell, E. S. (1981) Inhibition of theophylline metabolism by long-term allopurinol administration. Clin. Pharmacol. Ther., 29, 224–9.
Marbet, G. A., Duckert, F., Walter, M., Six, P. and Airenne, H. (1977) Interaction study between phenprocoumon and flurbiprofen. Curr. Med. Res. Opinion, 5, 26–31.
Meffin, P. J., Veenendaal, J. R. and Brooks, P. M. (1981) Diflunisal-probenecid co-disposition: Michaelis-Menten kinetics with competitive inhibition. Clin. Exp. Pharmacol. Physiol., 9, 605–11.
Melander, A. and Wâhlin-Bohl, E. (1981) Interaction of glipizide and indoprofen. Eur. J. Rheumatol. Inflammation, 4, 22–5.
Michot, F., Ajdacic, K. and Glaus, L. (1975) A double blind clinical trial to determine if an interaction exists between diclofenac sodium and the oral anticoagulant acenocoumarol (nicoumalone). J. Int. Med. Res., 3, 153–7.
Mielens, Z. E., Drobeck, H. P., Rozitis, J. and Sansone, V. J. (1968) Interaction of aspirin with non-steroidal anti-inflammatory drugs in rats. J. Pharm. Pharmacol., 20, 567–9.
Miller, D. R. (1981) Combination use of non-steroidal anti-inflammatory drugs. Drug Intell. Clin. Pharm., 15, 3–7.
Mills, E. H., Whitworth, J. A., Andrews, J. and Kincaird-Smith, P. (1982) Nonsteroidal anti-inflammatory drugs and blood pressure. Aust. N. Z. J. Med., 12, 478–82.
Miners, J. O., Foenander, T., Wanwimolruk, S., Gallus, S. and Birkett, D. J. (1982) The effect of sulphinpyrazone on oxidative drug metabolism in man: inhibition of tolbutamide elimination. Eur. J. Clin. Pharmacol., 22, 321–6.
Minn, F. L. and Zinny, M. A. (1980) Zomepirac and warfarin: a clinical study to determine if interaction exists. J. Clin. Pharmacol., 20, 418–21.
Mor, R., Pitlik, S. and Rosenfeld, J. B. (1983) Indomethacin- and moduretic-induced hyperkalaemia. Israeli J. Med. Sci., 19, 535–7.
Müller, F. O., Hundt, H. K. and Müller, D. G. (1977) Pharmacokinetic and pharmacodynamic implications of long-term administration of non steroidal anti-inflammatory agents. Int. J. Clin. Pharmacol. Biopharm., 15, 397–402.
Nayak, R. K., Smyth, R. D., Polk, A., Herczeg, T., Carter, V., Visalli, A. J. and Reavey-Cantwell, M. H. (1977) Effect of antacids on aspirin dissolution and bioavailability. J. Pharmacokin. Biopharm., 5, 597–613.
Nierenberg, D. W. (1983) Competitive inhibition of methotrexate accumulation in rabbit kidney slices by non-steroidal anti-inflammatory drugs. J. Pharmacol Exp. Ther., 226, 1–6.
Nies, A. S., Gal, J., Fadul, S. and Gerber, J. G. (1983) Indomethacin-furosemide interaction: the importance of renal blood flow. J. Pharmacol. Exp. Ther., 226, 27–32.
Nordoy, S. (1959) Combined treatment with phenylbutazone and anticoagulants. Tidssksift for den Norske Laegeforening, 79, 143.
O’Brien, J. R. (1968) The effect of salicylates on human platelets. Lancet, i, 779–83.
O’Malley, K., Stevenson, I. H. and Crooks, J. (1972) Impairment of human drug metabolism by oral contraceptive steroids. Clin. Pharmacol. Ther., 13, 552–7.
O’Reilly, R. A. (1973) The binding of sodium warfarin to plasma albumin and its displacement by phenylbutazone. Ann. N. Y. Acad. Sci., 226, 293–308.
O’Reilly, R, A. (1982a) Phenylbutazone and sulfinpyrazone interaction with oral anticoagulant phenprocoumon. Arch. Intern. Med., 142, 1634–7.
O’Reilly, R. A. (1982b) Stereoselective interaction of sulphinpyrazone with racemic warfarin and its separated enantiomers in man. Circulation, 65, 202–7.
O’Reilly, R. A. and Aggeler, P. M. (1968) Phenylbutazone potentiation of anticoagulant effect: fluorometric assay of warfarin. Proc. Soc. Exp. Biol. Med., 128, 1080–1.
O’Reilly, R. A., Sahud, M. A. and Aggeler, P. M. (1971) Impact of aspirin and chlorthalidone on the pharmacodynamics of oral anticoagulants in man. Ann. N. Y. Acad. Sci., 179, 173–86.
O’Reilly, R. A., Trager, W. F., Motley, C. H. and Howald, W. (1980) Stereoselective interaction of phenylbutazone with [12C/13C] warfarin pseudoracemates in man. J.Clin. Invest., 65, 746–53.
Ober, K. F. (1974) Mechanism of interaction of tolbutamide and phenylbutazone in diabetic patients. Eur. J. Clin. Pharmacol., 7, 291–4.
Olanow, C. W., Finn, A. and Prussak, C. (1979) The effect of salicylate on phenytoin pharmacokinetics. Trans. Am. Neurol. Assoc., 104, 109–10.
Oliw, E., Angaard, E. and Fredholm, B. (1977) Effect of indomethacin on the renal actions of theophylline. Eur. J. Pharmacol., 43, 9–16.
Oliw, E., Kover, G., Larsson, C. and Angaard, E. (1976) Reduction by indomethacin of furosemide effects in the rabbit. Eur. J. Pharmacol., 38, 95–100.
Olsen, U. B. (1975) Indomethacin inhibition of bumetanide diuresis in dogs. Acta Pharmacol. Toxicol., 37, 65–78.
Orr, J. M., Abbott, F. S., Farrell, K., Ferguson, S., Sheppard, I. and Godolphin, W. (1982) Interaction between valproic acid and aspirin in epileptic children: serum protein binding and metabolic effects. Clin. Pharmacol. Ther., 31, 642–9.
Oyer, J. H., Wagner, S. L. and Schmid, F. R. (1966) Suppression of salicylate-induced uricosuria by phenylbutazone. Am. J. Med. Sci., 251, 1–7.
Park, B. K. and Breckenridge, A. M. (1981) Clinical implications of enzyme induction and enzyme inhibition. Clin. Pharm., 6, 1–24.
Passen, M., Ferretti, G., Monica, C, Fanfani, A. and Bergamini, N. (1981) Study of the possible interactions of indoprofen on the diuretic effect of furosemide. Eur. J. Rheumatol. Inflammation, 4, 36–40.
Patak, R. V., Mookerjee, B. K., Bentzel, C. J., Hysert, P. E., Babe, M. and Lee, J. B. (1975) Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man. Prostaglandins, 10, 649–59.
Pawlotsky, Y., Durand, B., Delbary, A., Le Treut, A., Catheline, M. and Bourel, M. (1977) Reduction de l’activité de l’indométhacine par l’aspirine. Intérêt des mesures de l’indice articulaire et de la sigma V. S. Nouvelle Presse Méd., 6, 255–58.
Pawlotsky, Y., Châles, G., Grosbois, B., Miane, B. and Bourel, M. (1978) Comparative interaction of aspirin with indomethacin and sulindac in chronic rheumatic diseases. Eur. J. Rheumatol. Inflammation, 1, 18–20.
Paxton, J. W. (1980) Effects of aspirin on salivary and serum phenytoin kinetics in healthy subjects. Clin. Pharmacol. Ther., 27, 170–8.
Pedrazzi, F., Bommartini, F., Freddo, J. and Emanueli, A. (1981) A study of the possible interactions of indoprofen with hypoglycaemic sulphonylureas in diabetic patients. Eur. Rheumatol. Inflammation, 4, 26–31.
Pedrinelli, R., Magagna, A., Arzilli, F., Sassano, P. and Salvetti, A. (1980) Influence of indomethacin on the natriuretic and renin-stimulating effect of bumetanide in essential hypertension. Clin. Pharmacol. Ther., 28, 722–31.
Pedrinelli, R., Magagna A. and Salvetti, A. (1982) The effect of Oxprenolol and indomethacin on renin and aldosterone of normal subjects during low sodium diet. Eur. J. Clin. Invest., 12, 107–11.
Penner, J. A. and Abbrecht, P. H. (1975) Lack of interaction between ibuprof en and warfarin. Curr. Ther. Res., 18, 862–71.
Petereit, M. S. and Meikle, A. W. (1977) Effectiveness of prednisolone during phenytoin therapy. Clin. Pharmacol. Ther., 22, 912–16.
Pitkäjärvi, T., Pyykönen, M. L., Ylitalo, P., Nurmi, A-K., Seppälä, E. and Vapaatalo, H. (1983) Interaction of indomethacin and atenolol in essential hypertension. Proc. 2nd World Conf. Clin. Pharmacol. Ther., Abstract No. 5.
Pond, S. M., Birkett, D. J. and Wade, D. N. (1977) Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulphaphenazole. Clin. Pharmacol. Ther., 22, 573–9.
Powell-Jackson, P. R. (1977) Interaction between azapropazone and warfarin. Br. Med. J., 1, 1193–4.
Pullar, T. and Capell, H. A. (1982) Interaction of indomethacin and warfarin. Br. Med. J., 284, 198.
Quattrochi, F. P., Robinson, J. D., Curry, R. W., Grieco, M. L. and Schulman S. G. (1983) The effect of ibuprof en on serum digoxin concentrations. Drug Intell. Clin. Pharm., 17, 286–8.
Rae, S. A., Williams, I. A., English, J. and Baylis, E. M. (1982) Alteration of plasma prednisolone levels by indomethacin and naproxen. Br. J. Clin. Pharm., 14, 459–61.
Ragheb, M., Ban, T. A., Buchanan, D. and Frolich, J. C. (1980) Interaction of indomethacin and ibuprofen with lithium in manic patients under a steady-state lithium level. J. Clin. Psychiatr., 41, 397–8.
Rawles, J. M. (1982) Antagonism between non-steroidal anti-inflammatory drugs and diuretics. Scott. Med. J., 27, 37–40.
Reimann, I. W. and Frölich, J. C. (1981) Effects of diclofenac on lithium kinetics. Clin. Pharmacol. Ther., 30, 348–53.
Reimann, I. W., Diener, U. and Frölich, J. C. (1983) Indomethacin but not aspirin increases plasma lithium ion levels. Arch. Gen. Psychiatr., 40, 283–6.
Reinicke, C. and Vesel, G. (1979) Pharmacokinetic interactions between non-steroidal antirheumatism agents. Vutreshni Bolesti, 18, 76–82.
Roberts, C. J. C., Daneshmend, T. K., Macfarlane, D. and Dieppe, P. A. (1981) Anticonvulsant intoxication precipitated by azapropazone. Postgrad. Med. J., 57, 191–2.
Rolf-Smith, S., Gibson, R., Bradley, D. and Kendall, M. J. (1983) Failure of indomethacin to modify ß-adrenoceptor blockade. Br. J. Clin. Pharmacol., 15, 267–8.
Romero, J. C. and Strong, C. G. (1977) The effect of indomethacin blockade of prostaglandin synthesis on blood pressure of normal rabbits and rabbits with renovascular hypertension. Circ. Res., 40, 35–41.
Rubin, A., Chernish, S. M., Crabtree, R., Gruber, C. M., Helleberg, L., Rodda, B. E., Warrick, P., Wolen, R. L. and Ridolfo, A. S. (1974) A profile of the physiological disposition and gastrointestinal effects of feno’profen in man. Curr. Med. Res. Opinion, 2, 529–43.
Rubin, A., Rodda, B. E., Warrick, P., Gruber, C. M. and Ridolfo, A. S. (1973) Interaction of aspirin with non-steroidal anti-inflammatory drugs in man. Arthr. Rheum., 16, 635–45.
Rubin, P. C, Jackson, G. and Blaschke, T. F. (1980) Studies on the clinical pharmacology of prazosin II: the influence of indomethacin and of propranolol on the action and disposition of prazosin. Br. J. Clin. Pharmacol., 10, 33–40.
Rudgé, S. R., Lloyd-Jones, J. K. and Hind, I. D. (1982) Interaction between flurbiprofen and indomethacin in rheumatoid arthritis. Br. J. Clin. Pharmacol., 13, 448–51.
Rumble, R. H., Brooks, P. M. and Roberts, M. S. (1979) Interaction between levamis-ole and aspirin in man. Br. J. Clin. Pharmacol., 7, 631–3.
Runkel, R., Mroszczak, E., Chaplin, M., Sevelius, H. and Segre, E. (1978) Naproxen-probenecid interaction. Clin. Pharmacol. Ther., 24, 706–13.
Rust, O., Biland, L., Thilo, D., Nyman, D. and Duckert, F. (1975) Testing of the antirheumatic drug tolmetin for interaction with oral anticoagulants. Schweizische medizin. Wochenschr., 105, 752–3.
Ryan, J. R., Jain, A. K., McMahon, F. G. and Vargas, R. (1977) On the question of an interaction between sulindac and tolbutamide in the control in diabetes. Clin. Pharmacol. Ther., 21, 231–3.
Sachse Von, G., Willms, B. and Becker, R. (1979) Interaction between naproxen and tolbutamide on metabolism in diabetes. Arzneim. Forsch., 29, 835–6.
Salvetti, A., Arzilli, F., Pedrinelli, R., Beggi, P. and Motolese, M. (1982) Interaction between Oxprenolol in essential hypertensive patients. Eur. J. Clin. Pharmacol., 22, 197–201.
Sandyk, R. (1982) Phenytoin toxicity induced by interaction with ibuprof en. S. Afr. Med. J., 62, 592.
Savitsky, J. P., Terzakis, T., Bina, P., Chicarelli, F. and Haynes, J. (1980) Fenbufen-warfarin interaction in healthy volunteers. Clin. Pharmacol. Ther., 27, 284.
Schäfer-Körting, M., Kirch, W., Axthelm, T., Köhler, H. and Mutschier, E. (1983) Atenolol interaction with aspirin, allopurinol and ampicillin. Clin. Pharmacol. Ther., 33, 283–8.
Senary, W. L., Aarons, L. J. and Rowland, M. (1978) Representation and interpretation of drug displacement interactions. Biochem. Pharmacol., 27, 139–46.
Schenk, H. Klein, G., Haralambus, I. and Goebel, R. (1980) Coumarintherapie unter dem Antirheumaticum Sulindac. Z. Rheumatol., 39, 102–8.
Schiffman, F. J., Uehara, Y., Fisher, J. M. and Rabinovitz, M. (1978) Potentiation of chlorambucil activity by phenylbutazone. Cancer Lett., 4, 211–16.
Schobben, F., Vree, T. B. and van der Kleijn, E. (1978) Pharmacokinetics, metabolism and distribution of 2-N-Propyl pentanoate (sodium valproate) and the influence of salicylate co-medication, in Advances in Epileptology — 1977 (eds M. Meinardi and T. Rowan), Swets and Zeitlinger, Amsterdam, pp. 271–7.
Schulz P., Perrier, C. V., Ferber-Perret, F., Vandenheuval, W. J. and Steelman, S. L. (1979) Diflunisal, a new-acting analgesic and prostaglandin inhibitor: effect of concomitant acetylsalicylic acid therapy on ototoxicity and on disposition of both drugs. J. Int. Med. Res., 7, 61–8.
Segre, E. (1979) Drug interactions with naproxen. Eur. J. Rheumatol. Inflammation, 2, 12–18.
Segre, E. J., Chaplin, M., Forchielli, E., Runkel, R. and Sevelius, H. (1974b) Naproxen-aspirin interactions in man. Clin. Pharmacol. Ther., 15, 374–9.
Segre, E. J., Sevelius, H. and Varady, J. (1974a) Effect of antacids on naproxen absorption. N. Engl. J. Med., 291, 582–3.
Seiler, K. and Duckert, F. (1968) Properties of 3-(l-phenyl-propyl)-4-oxycoumarin (Marcoumar) in the plasma when tested in normal cases and under the influence of drugs. Thromb. Diathes. Haemorrhag., 19, 89–96.
Sellers, E. M. and Koch-Weser, J. (1970) Displacement of warfarin from human albumin by diazoxide, and ethacrynic, mefenamic and nalidixic acids. Clin. Pharmacol. Ther., 11, 524–9.
Serlin, M. J., Mossman, S., Sibeon, R. G., Tempero, K. F. and Breckenridge, A. M. (1980) Interaction between diflunisal and warfarin. Clin. Pharmacol. Ther., 28, 493–8.
Shen, D. D. and Azarnoff, D. L. (1978) Clinical pharmacokinetics of methotrexate. Clin. Pharmacokinet., 3, 1–13.
Silberbauer, K. Stanek, B. and Tempi, H. (1982) Acute hypotensive effect of Captopril in man modified by prostaglandin synthesis inhibition. Br. J. Clin. Pharmacol., 14 (Suppl. 2), 87S–93S.
Singer, L., Imbs, J. L., Schmidt, M., Mack, G., Sebban, M. and Danion, J. M. (1978) Baisse de la clairance rénale du lithium sous l’effet de la phenylbutazone. Encéphale, 4, 33–40.
Skeith, M. D., Simkin, P. A. and Healey, L. A. (1968) The renal excretion of indomethacin and its inhibition by probenecid. Clin. Pharmacol. Ther., 9, 89–93.
Slack, B. L., Warner, M. E. and Keiser, H. R. (1978) The effect of prostaglandin synthetase inhibition on the action of hydralazine. Circulation, 58, 21.
Slade, I. H. and Iosefa, R. N. (1967) Fatal hypoglycemic coma from the use of tolbutamide in elderly patients: Report of two cases. J. Am. Geriatr. Soc., 15, 948–50.
Slattery, J. T., Levy, G., Jain, A. and McMahon, F. G. (1979) Effect of naproxen on the kinetics of elimination and anticoagulant activity of a single dose of warfarin. Clin. Pharmacol. Ther., 25, 51–60.
Smith, D. E., Brater, D. C., Lin, E. T. and Bener, L. Z. (1979) Attenuation of furosemide’s diuretic effect by indomethacin: pharmacokinetic evaluation. J. Pharmacokinet. Biopharm., 7, 265–74.
Solomon, H. M. and Abrams, W. B. (1972) Interactions between digitoxin and other drugs in man. Am. Heart J., 83, 277–80.
Solomon, H. M., Reich, S., Spirt, N. and Abrams, W. B. (1971) Interactions between digitoxin and other drugs in vitro and in vivo. Ann. N. Y. Acad. Sci., 179, 362–8.
Solomon, H. M., Schrogie, J. J. and Williams, D. (1968) The displacement of phenylbutazone 14C and warfarin 14C from human albumin by various drugs and fatty acids. Biochem. Pharmacol., 17, 143–51.
Spät, A., Józan, S., Gaál, K. and Mózes, T. (1977) Effect of indomethacin on the adrenal response to furosemide in the rat. J. Endocrinol., 73, 401–2.
Steelman, S. L., Cirillo, V. J. and Tempero, K. F. (1978) The chemistry, pharmacology and clinical pharmacology of diflunisal. Curr. Med. Res. Opinion, 5, 506–14.
Steiness, E, and Waldorff, S. (1982) Different interactions of indomethacin and sulindac with thiazides in hypertension. Br. Med. J., 285, 1702–3.
Stitt, F. W., Latour, R. and Frane, J. W. (1977) A clinical study of naproxen-diazepam drug interaction on tests of mood and attention. Curr. Ther. Res., 21, 149–56.
Stowers, J. M., Constable, L. W. and Hunter, R. B. (1959) A clinical and pharmacological comparison of chlorpropamide and other sulphonylureas. Ann. N. Y. Acad. Sci., 74, 689–95.
Strieker, B. H. and Delhez, J. L. (1982) Interactions between flurbiprofen and coumarins. Br. Med. J., 285, 812–13.
Swanson, B. N., Boppana, V. K., Masses, P. H., Rotmensch, H. H. and Ferguson, R. K. (1983) Dimethylsulphoxide inhibits bioactivation of sulindac. J. Lab. Clin. Med., 102, 95–101.
Symmons, D. P. M., Kendall, M. J., Rees, J. A. and Hind, I. D. (1983) The effect of flurbiprofen on the response to frusemide in healthy volunteers. Int. J. Clin. Pharmacol. Ther. Toxicol., 21, 350–4.
Sziegoleit, W., Rausch, J., Polâk Gy., Gyorgy, M., Dekov, E. and Békés, M. (1982) Influence of acetylsalicylic acid on acute circulatory effects of the beta-blocking agents pindolol and propranolol in humans. Int. J. Clin. Pharmacol. Ther. Toxicol., 20, 423–30.
Szita, M., Gachalyi, B., Tornyossy, M. and Kaldor, A. (1980) Interaction of phenylbutazone and tolbutamide in man. Int. J. Clin. Pharmacol. Ther. Toxicol., 18, 378–80.
Tannenbaum, H., Anderson, L. G. and Saeldner, J. S. (1974) Phenylbutazone-tolbutamide drug interaction. N. Engl. J. Med., 290, 344.
Tempero, K. F., Cirillo, V. J. and Steelman, S. L. (1977) Diflunisal: a review of pharmacokinetic and pharmacodynamic properties, drug interactions, and special tolerability studies in humans. Br. J. Clin. Pharmacol., 4 (Suppl. 1), 31S–36S.
Thadani, U., Kellerman, D., Martin, T. and Glenn, T. (1983) Effects of indomethacin on haemodynamics and exercise tolerance in angina pectoris. Clin. Pharmacol. Ther., 33, 211.
Thomsen, P. E. B., Ostenfeld, H. O. L. and Kristensen, M. (1970) Chlorpropamide-phenylbutazone as the cause of hypoglycaemia. A case of an unfortunate drug combination. Ugeskrift for Laeger, 137, 1722–4.
Tiggeler, R. E. W., Koena, R. A. P. and Wijdeveld, P. G. A. B. (1977) Inhibition of furosemide-induced natriuresis by indomethacin in patients with the nephrotic syndrome. Clin. Sci. Mol. Med., 52, 149–51.
Tjandramaga, T. B., Verbesselt, R., Van Hecken, A., de Schepper, P. J. (1983) Difluni-sal-indomethacin interaction: evidence for impaired indomethacin-glucuronide formation. Proc. 2nd World Conf. Clin. Pharmacol. Ther., Abstract No. 28.
Tobert, J. A., De Schepper, P., Tjandramaga, T. B., Mullie, A., Buntinx, A. P., Meisinger, M. A. P., Huber, P. B., Hall, T. L. P. and Yeh, K. C. (1981) Effects of antacids on the bioavailability of diflunisal in the fasting and postprandial states. Clin. Pharmacol. Ther., 30, 385–9.
Torgyan, S., Wagner, L., Neumann, T., Pakuts, B. and Csanyi, M. (1979) A comparative study with indomethacin and combined indomethacin—sodium salicylate in rheumatoid arthritis. Int. J. Clin. Pharmacol. Biopharm., 17, 439–41.
Tweedale, M. G. and Ogilvie, R. I. (1973) Antagonism of Spironolactone-induced natriuresis by aspirin in man. N. Engl. J. Med., 289, 198–200.
Udall, J. A. (1969) Drug interference with warfarin. Am. J. Cardiol.23, 143.
Upton, R. A., Williams, R. L., Buskin, J. N. and Jones, R. M. (1982) Effects of probenecid on ketoprofen kinetics. Clin. Pharmacol. Ther., 31, 705–12.
Valette, H, and Apoil, E. (1979) Interaction between salicylate and two loop diuretics. Br. J. Clin. Pharmacol., 8, 592–4.
Van Arman, C. G., Nuss, G. W. and Risley, E. A. (1973) Interactions of aspirin, indomethacin and other drugs in adjuvant induced arthritis in the rat. J. Pharmacol. Exp. Ther., 187, 400–14.
Verbeeck, R., Tjandramaga, T. B., Mullie, A., Verbesselt, R. and De Schepper, P. J. (1979) Effect of aluminium hydroxide on diflunisal absorption. Br. J. Clin. Pharmacol., 7, 519–22.
Verbeek, R. K., Blackburn, J. L. and Loewen, G. R. (1983) Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs. Clin. Pharmacokinet., 8, 297–331.
Vesell, E. S., Passananti, G. T. and Green, F. E. (1970) Impairment of drug metabolism in man by allopurinol and nortryptiline. N. Engl. J. Med., 283, 1484–8.
Vesell, E. S., Passananti, G. T. and Johnson, A. O. (1975) Failure of indomethacin and warfarin to interact in normal human volunteers. J. Clin. Pharmacol., 15, 486–95.
Vierhopper, H., Waldhausl, W. and Nowotny, P. (1981) Effect of indomethacin upon angiotensin-induced changes in blood pressure and plasma aldosterone in normal man. Eur. J. Clin. Invest., 11, 85–9.
Viswanathan, C. T. and Levy, R. H. (1981) Plasma protein binding interaction between valproic and salicylic acids in rhesus monkeys. J. Pharm. Sci., 70, 1279–81.
Voigt, U. and Klassen, E. (1982) Zur Prüfung von Ketoprofen auf Interaktionon mit oraler Antidiabetika. Medizin. Welt, 33, 1592–3.
Walter, E., Staiger, Ch., De Vries, J., Zimmerman, R. and Weber, E. (1981) Induction of drug metabolising enzymes by sulphinpyrazone. Eur. J. Clin. Pharmacol., 19, 353–8.
Wanwimolruk, S., Birkett, D. J. and Brooks, P. M. (1982) Protein binding of some nonsteroidal anti-inflammatory drugs in rheumatoid arthritis. Clin. Pharmacokinet., 7, 85–92.
Watkins, J., Abbott, E. C, Hensby, C. N., Webster, J. and Dollery, C. T. (1980) Attenuation of hypotensive effect of propranolol and thiazide diuretics by indo-methacin. Br. Med. J., 281, 702–5.
Weber, P. C., Scherer, B. and Larsson, C. (1977) Increase of free arachidonic acid by furosemide in man as the cause of prostaglandin and renin release. Eur. J. Pharmacol., 41, 329–32.
Weber, S., Daoud, H., Richard, M. O., Rey, E., Olive, G., Guerin, F. and Degeorges, M. (1983) Influence of aspirin on the haemodynamic effects of nitroglycerin. Proc. 2nd World Conf. Clin. Pharmacol. Ther., Abstract No. 138.
Webster, J., Hawksworth, G. M., McLean, I. and Pétrie, J. C. (1983) Attenuation of the antihypertensive effect of single doses of propranolol and atenolol by flurbiprofen. Proc. 2nd World Conf. Clin. Pharmacol. Ther., Abstract No. 2.
Weiner, M., Siddiqui, A. A., Bostanci, N. and Dayton, P. G. (1965) Drug interaction -the effect of combined administration on the halflife of coumarin and pyrazolone drugs in man. Fed. Proc, 24, 153.
Wennmalm, A., Eriksson, S., Hagerfeldt, L., Law, D., Patrono, C. and Pinea, E. (1983) Effect of prostaglandin synthesis inhibitors on basal and carbon dioxide stimulated cerebral blood flow in man, in Advances in Prostaglandin, Thromboxane and Leukotriene Research (eds B. Samuelsson, R. Paoletti and P. W. Ramwell), Vol. 12, Raven Press, New York.
Whiting, B., Lorenzi, M., Robins, D. S. and Williams, R. (1979) The influence of naproxen on glucose metabolism and tolbutamide pharmacologic effect. Clin. Pharmacol. Ther., 25, 253.
Whitsett, T. L., Barry, J. P., Czerwinski, A. W., Hall, W. H. and Hampton, J. W. (1975) Interaction of tolmetin and warfarin: A clinical investigation, in Tolmetin a New Non-steroidal Anti-inflammatory Agent (ed. J. Ward), Excerpta Medica, Princeton.
Wilkerson, R. D. and Glenn, T. M. (1977) Influence of non-steroidal anti-inflammatory drugs on ouabain toxicity. Am. Heart]., 94, 454–9.
Wilkerson, R. D., Mockridge, P. B. and Massing, G. K. (1980) Effect of selected drugs on serum digoxin concentration in dogs. Am. J. Cardiol.45, 1201–10.
Williams, R. L., Davies, R. O., Berman, R. S., Holmes, G. I., Huber, P., Gee, W. L., Lin, E. T. and Benet, L. Z. (1982) Hydrochlorthiazide pharmacokinetics and pharmacologic effect: the influence of indomethacin. J. Clin. Pharmacol.22, 32–41.
Williams, R. L., Upton, R. A., Buskin, J. N. and Jones, R. M. (1981) Ketoprofen-aspirin interactions. Clin. Pharmacol. Ther., 30, 226–31.
Williamson, H. E., Bourland, W. A. and Marchand, G. R. (1974) Inhibition of ethacrinic acid-induced increase in renal blood flow by indomethacin. Prostaglandins, 8, 297–301.
Williamson, H. E., Bourland, W. A. and Marchand, G. R. (1975) Inhibition of furosemide induced increase in renal blood flow by indomethacin. Proc. Soc. Exp. Biol. Med., 148, 164–7.
Williamson, P., Ene, D. and Roberts, C. (1983) Effects of azapropazone and frusemide on renal sodium and urate excretion. Proc. 2nd World Conf. Clin. Pharmacol. Ther., Abstract No. 249.
Williamson, P. J., Daneshmend, T. K., Ene, M. D. and Roberts, C. J. C. (1984) Antipyrine kinetics during administration of azapropazone and frusemide. Br. J. Clin. Pharmacol., 17, 627P.
Willis, J. V., Kendall, M. J. and Jack, D. B. (1980) A study of the effect of aspirin on the pharmacokinetics of oral and intravenous diclofenac sodium. Eurl J. Clin. Pharmacol., 18, 415–18.
Willkens, R. F. and Segre, E. J. (1975) Combination therapy with naproxen and aspirin in rheumatoid arthritis. Arthr. Rheum., 19, 677–82.
Wing, L. M. H., Bune, A. J. C, Chalmers, J. P., Graham, J. R. and West, M. J. (1981) The effects of indomethacin in treated hypertensive patients. Clin. Exp. Pharmacol. Physiol., 8, 537–41.
Wiseman, E. H., Chang, Y-H. and Hobbs, D. C. (1975) Interaction of sudoxicam and aspirin in animals and man. Clin. Pharmacol. Ther., 18, 441–8.
Wishinsky, H., Glasser, E. J. and Perkal, S. (1962) Protein interactions of sulphonylurea compounds. Diabetes, 2 (Suppl), 18–25.
Witzgall, H., Hirsch, F., Scherer, B. and Weber, P. C. (1982) Acute haemodynamic and hormonal effects of Captopril are diminished by indomethacin. Clin. Sci., 62, 611–15.
Yesair, D. W., Remington, L., Callahan, M. and Kensler, C. J. (1970) Comparative effects of salicylic acid, phenylbutazone, probenecid and other anions on the metabolism, distribution and excretion of indomethacin by rats. Biochem. Pharmacol., 19, 1591–600.
Yeung Laiwah, A. C. and Mactier, R. A. (1981) Antagonistic effect of non-steroidal anti-inflammatory drugs on frusemide induced cardiac failure. Br. Med. J., 283, 714.
Yü, T. F. and Perel J. (1980) Pharmacokinetic and clinical studies of carprofen in gout. J. Clin. Pharmacol., 20, 347–51.
Yü, T. F., Dayton, P. G. and Gutman, A. B. (1963) Mutual suppression of the uricosuric effects of sulfinpyrazone and salicylate: a study in interactions between drug. J. Clin. Invest., 42, 1330–9.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 J. M. H. Moll, H. A. Bird and A. Rushton
About this chapter
Cite this chapter
Orme, M.C.L. (1986). Drug interactions. In: Moll, J.M.H., Bird, H.A., Rushton, A. (eds) Therapeutics in Rheumatology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2883-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-4899-2883-2_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-24540-4
Online ISBN: 978-1-4899-2883-2
eBook Packages: Springer Book Archive